Addex Therapeutics (ADXN) News Today $8.04 -0.69 (-7.85%) As of 08/28/2025 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADXN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Addex Therapeutics Ltd (ADXN) - Yahoo FinanceJuly 17, 2025 | finance.yahoo.comADXN - Addex Therapeutics Ltd Price vs Fair Value - MorningstarJuly 2, 2025 | morningstar.comMStalicla secures CHF 2M investment led by Addex for neuropsychiatric drug developmentJune 30, 2025 | seekingalpha.comStalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder ProgramsJune 30, 2025 | globenewswire.comAddex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric DisordersJune 30, 2025 | globenewswire.comAddex Shareholders Approve All Resolutions at Annual General MeetingJune 25, 2025 | globenewswire.comAddex Therapeutics Ltd (ADXN) Q1 2025 Earnings Call Highlights: Strategic Advances and ...June 20, 2025 | finance.yahoo.comAddex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate UpdateJune 19, 2025 | globenewswire.comAddex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025June 18, 2025 | globenewswire.comAddex Therapeutics: Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical ModelsJune 6, 2025 | finanznachrichten.deAddex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical ModelsJune 6, 2025 | globenewswire.comAddex Convenes Annual General Meeting 2025June 3, 2025 | globenewswire.comAddex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling StudiesMay 12, 2025 | globenewswire.comAddex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury RecoveryApril 30, 2025 | globenewswire.comAddex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Highlights: Strategic Spinout and Financial ...April 26, 2025 | gurufocus.comQ4 2024 Addex Therapeutics Ltd Earnings Call TranscriptApril 25, 2025 | gurufocus.comAddex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call TranscriptApril 25, 2025 | seekingalpha.comAddex Therapeutics: Addex Reports Full Year 2024 Financial Results and Provides Corporate UpdateApril 25, 2025 | finanznachrichten.deAddex Reports Full Year 2024 Financial Results and Provides Corporate UpdateApril 25, 2025 | globenewswire.comAddex Therapeutics Ltd American Depositary Shares (ADXN)April 23, 2025 | nasdaq.comAddex Therapeutics regains rights to ADX71149April 17, 2025 | markets.businessinsider.comAddex Therapeutics: Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149April 17, 2025 | finanznachrichten.deAddex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149April 17, 2025 | globenewswire.comAddex to Present at the 2025 Swiss Equities Baader ConferenceJanuary 8, 2025 | globenewswire.comAddex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...November 23, 2024 | gurufocus.comQ3 2024 Addex Therapeutics Ltd Earnings Call TranscriptNovember 22, 2024 | gurufocus.comQ3 2024 Addex Therapeutics Ltd Earnings Call TranscriptNovember 22, 2024 | gurufocus.comAddex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call TranscriptNovember 22, 2024 | seekingalpha.comAddex Therapeutics Q3 Net Loss Narrows, Income DropsNovember 22, 2024 | markets.businessinsider.comAddex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 22, 2024 | globenewswire.comAddex Therapeutics Q3 2024 Earnings Preview: What Investors Need to KnowNovember 21, 2024 | theglobeandmail.comAddex Therapeutics: Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024November 12, 2024 | finanznachrichten.deAddex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024November 11, 2024 | globenewswire.com3 Growth Companies With High Insider Ownership On The SIX Swiss ExchangeOctober 12, 2024 | finance.yahoo.comBuy Rating Affirmed for Addex Therapeutics Amid Promising Clinical Developments and Strategic Neurosterix SpinoutOctober 3, 2024 | markets.businessinsider.comAddex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...October 1, 2024 | finance.yahoo.comAddex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateSeptember 30, 2024 | globenewswire.comAddex Therapeutics: Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitSeptember 20, 2024 | finanznachrichten.deAddex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitSeptember 19, 2024 | globenewswire.comAddex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comPositive Outlook for Addex Therapeutics: Significant Collaboration Payments and Promising Pipeline Drive Buy RatingAugust 28, 2024 | markets.businessinsider.comClinical Collaboration Ignites Addex Therapeutics (ADXN) Stock RallyAugust 28, 2024 | msn.comCrude Oil Dips; Addex Therapeutics Shares Spike HigherAugust 27, 2024 | benzinga.comAddex Therapeutics: Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationAugust 27, 2024 | finanznachrichten.deJohnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use DisorderAugust 27, 2024 | finance.yahoo.comAddex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationAugust 27, 2024 | globenewswire.comAddex Therapeutics Insider Ups Holding By 71% During YearAugust 19, 2024 | finance.yahoo.comCK Life Sciences Int'l., (Holdings) Inc. (LSI.F)August 15, 2024 | finance.yahoo.comBuy Rating Affirmed for Addex Therapeutics Amid Strategic Spinout and Promising Drug PipelineJuly 31, 2024 | markets.businessinsider.comAddex Therapeutics Ltd (APE1.MU)July 24, 2024 | sg.finance.yahoo.com Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADXN Media Mentions By Week ADXN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADXN News Sentiment▼1.881.03▲Average Medical News Sentiment ADXN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADXN Articles This Week▼10▲ADXN Articles Average Week Get the Latest News and Ratings for ADXN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Addex Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RenovoRx News Dyadic International News Clearside Biomedical News Iterum Therapeutics News Tharimmune News Kezar Life Sciences News CASI Pharmaceuticals News Allarity Therapeutics News Promis Neurosciences News Akari Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADXN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access